WeChat Mini Program
Old Version Features

Nivolumab and Ipilimumab in Combination with Radiotherapy in Patients with High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck.

Jennifer M. Johnson,Ioannis A. Vathiotis,Larry A. Harshyne,Ayesha Ali,Voichita Bar Ad,Rita Axelrod,Emily Lorber,Joseph Curry,David M. Cognetti,Adam J. Luginbuhl,Madalina Tuluc,Scott Keith,My G. Mahoney,Athanassios Argiris

JOURNAL FOR IMMUNOTHERAPY OF CANCER（2023）

Cited 2|Views63
Key words
Nivolumab,Ipilimumab,Immunotherapy,Radiotherapy,Head and Neck Neoplasms
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined